P. Chan et al., (-801 DOES NOT PREVENT MPTP-INDUCED LOSS OF NIGRAL NEURONS IN MICE()MK), The Journal of pharmacology and experimental therapeutics, 280(1), 1997, pp. 439-446
The present study was designed to evaluate the effects of 0,11-dihydro
-5H-dibenzo[a,d]cyclohepten-5,10-imine [(+)MK-801] on 1-methyl-4-pheny
l-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage in th
e mouse, with the goal of clearly defining what protective effects, if
any, this noncompetitive N-methyl-phenyl-1,2,3,6-tetrahydropyridine r
eceptor antagonist may have against MPTP neurotoxicity. Animals were t
reated with MPTP (40 mg/kg s.c.) and/or (+)MK-801 (3 x 1 mg/kg i.p. at
4-hr intervals starting 30 min before MPTP) and were killed at 8 hr a
nd 1, 7 and 21 days after MPTP exposure, Dopamine concentrations were
measured in the striatum and ventral mesencephalon, and the total numb
er of neurons in the substantia nigra was estimated using an unbiased
stereological technique. Administration of(+)MK-801 before MPTP tempor
arily prevented MPTP-induced dopamine depletion. This was observed at
8 hr in the striatum and 1 week in the ventral mesencephalon, but not
at other time-points studied. In both areas of the brain, (+)MK-801 ap
peared to delay the elimination of the metabolite 1-methyl-4-phenylpyr
idinium ion without affecting its formation. A 30% loss of nigral neur
ons with tyrosine hydroxylase immunoreactive and cresyl violet stainin
g was seen at 1 and 3 weeks in both groups of MPTP-exposed animals, re
gardless of whether they received (+)MK-801. These data suggest that (
+)MK-801 may affect the acute pharmacological/biochemical events induc
ed by MPTP, but it does not have any enduring protective effects on ei
ther dopamine concentrations and/or the cell loss induced by this neur
otoxin in mice.